Bio-Technology General Overview
- Year Founded
-
1980
- Status
-
Acquired/Merged
- Employees
-
324
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
1
Bio-Technology General General Information
Description
Manufacturer and developer of human health care products based in Kiryat Malachi, Israel. The company's products include large-scale bacterial fermentation, mammalian cell culture, macromolecular separation and purification, aseptic filling of highly viscous liquids in prefilled syringes and recombinant human growth hormone as well as injectable system, thereby lubricating the eye and maintaining low intraocular pressure while facilitating surgery to reduce trauma to the corneal endothelium.
Contact Information
Website
www.btgil.com(Operating Subsidiary)
Corporate Office
- Beer Tuvia Industrial Zone
- Post Box 571
- Kiryat Malakhi 8310402
- Israel
Corporate Office
- Beer Tuvia Industrial Zone
- Post Box 571
- Kiryat Malakhi 8310402
- Israel
Bio-Technology General Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bio-Technology General Patents
Bio-Technology General Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250034206-A1 | Method of protein purification | Pending | 08-Dec-2021 | ||
| WO-2020016820-A1 | Process of, and arrangement for, sterile filtering a non-newtonian liquid and formulation of a liquid obtainable thereby | Inactive | 18-Jul-2018 | ||
| WO-2009063307-A2 | Inflammatory activity detection method using il-6 | Inactive | 14-Nov-2007 | ||
| WO-2009063307-A3 | Inflammatory activity detection method using il-6 | Inactive | 14-Nov-2007 | ||
| WO-2009063307-A8 | Inflammatory activity detection method using il-6 | Inactive | 14-Nov-2007 | G01N33/6869 |
Bio-Technology General Signals
Bio-Technology General Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bio-Technology General Investments (1)
Bio-Technology General’s most recent deal was a Later Stage VC with Gamida Cell for . The deal was made on 27-Sep-2006.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gamida Cell | 27-Sep-2006 | Later Stage VC | Biotechnology |
Bio-Technology General Exits (1)
Bio-Technology General’s most recent exit was on 27-Sep-2006 from Gamida Cell. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Gamida Cell | 27-Sep-2006 | Completed |
|
Bio-Technology General FAQs
-
When was Bio-Technology General founded?
Bio-Technology General was founded in 1980.
-
Where is Bio-Technology General headquartered?
Bio-Technology General is headquartered in Kiryat Malakhi, Israel.
-
What is the size of Bio-Technology General?
Bio-Technology General has 324 total employees.
-
What industry is Bio-Technology General in?
Bio-Technology General’s primary industry is Pharmaceuticals.
-
Is Bio-Technology General a private or public company?
Bio-Technology General is a Private company.
-
What is Bio-Technology General’s current revenue?
The current revenue for Bio-Technology General is .
-
Who are Bio-Technology General’s investors?
Savient Pharmaceuticals has invested in Bio-Technology General.
-
When was Bio-Technology General acquired?
Bio-Technology General was acquired on 01-Jul-2005.
-
Who acquired Bio-Technology General?
Bio-Technology General was acquired by Ferring.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process